GA-ON LTD
Company number 13124435 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
GA-ON LTD - Analysis Report
Company Number: 13124435
Analysis Date: 2025-07-20 12:50 UTC
Financial Health Assessment for GA-ON LTD (as of 31 July 2024)
1. Financial Health Score: D
Explanation:
GA-ON LTD exhibits persistent negative net assets and net current liabilities over multiple years, indicating ongoing financial distress. The company's working capital position is weak, and shareholder funds are negative. While the company remains active and compliant with filing deadlines, these symptoms suggest significant financial strain that requires urgent attention.
2. Key Vital Signs
| Metric | Latest (2024-07-31) | Interpretation |
|---|---|---|
| Current Assets | £1,029 | Very low liquidity; insufficient short-term resources to cover immediate debts. |
| Current Liabilities | £3,728 | Obligations due within one year exceed available assets significantly. |
| Net Current Assets | -£2,699 | Negative working capital; "symptom of cash flow distress." |
| Net Assets (Shareholder Equity) | -£3,999 | Company value is negative; liabilities exceed total assets; "balance sheet weakness." |
| Share Capital | £1.00 | Minimal equity base; limited buffer against losses. |
| Average Number of Employees | 1 | Micro entity with very small operational scale. |
| Overdue Filings | No | Compliance "vital sign" is healthy; no regulatory distress. |
3. Diagnosis
GA-ON LTD is exhibiting clear "symptoms of financial distress." The company’s net current liabilities and negative net assets over the last three financial years reveal an ongoing inability to generate or maintain sufficient operational cash to cover short-term debts. This indicates possible liquidity challenges and an erosion of capital.
Liquidity Concerns: The company holds very low current assets (cash/debtors) compared to current liabilities, implying a weak "cash flow pulse." This may limit the firm's ability to fund day-to-day operations or meet creditor demands without external support.
Capital Deficiency: Negative shareholder funds indicate that accumulated losses have exceeded initial equity investment. This "balance sheet anemia" undermines stakeholder confidence and may restrict borrowing capacity.
Operational Scale: As a micro-entity with only one employee and minimal capital, GA-ON LTD may be in an early or developmental stage, or facing operational challenges that prevent growth.
Governance: The company remains compliant with filing deadlines, which is a positive sign and suggests management is attentive to regulatory requirements.
4. Recommendations
To restore financial wellness and strengthen the company’s fiscal "heart," the following actions are advised:
Enhance Liquidity Management:
- Pursue prompt collection of any receivables and manage payables carefully to improve working capital.
- Consider negotiating extended payment terms with creditors to ease short-term cash pressure.
Capital Injection or Funding:
- Inject additional equity capital to bolster shareholder funds and provide a financial cushion.
- Explore external financing options (e.g., loans, grants) if appropriate, but cautiously to avoid exacerbating liabilities.
Cost Control and Business Model Review:
- Review operational expenses to reduce overheads and improve the bottom line.
- Assess business model viability and explore revenue growth opportunities or strategic pivots if current operations are not generating sufficient income.
Regular Financial Monitoring:
- Implement monthly cash flow forecasts and financial reviews to detect and address issues early.
- Engage professional advisory support if needed to guide restructuring or turnaround efforts.
Stakeholder Communication:
- Maintain transparent communication with shareholders and creditors to manage expectations and build trust.
Medical Analogy Summary:
GA-ON LTD’s financial "vital signs" show a "weak pulse" with symptoms of liquidity stress and balance sheet weakness, akin to a patient with chronic illness needing immediate intervention to avoid further deterioration. Timely treatment through capital support and operational adjustments is critical to restore financial health.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.